Vision Biotechnology

Executive Summary

Vision Biotechnology, founded in 2018 and headquartered in Zurich, has rapidly established itself as a global player in the diagnostics industry, with its innovative solutions trusted in over 112 countries. The company's robust network of distributors and partners ensures its diagnostic tests and instruments are accessible in clinical laboratories, hospitals, and practices across Europe, Asia, the Americas, and Africa. Vision Biotechnology focuses on delivering reliable, high-quality diagnostic tools that address critical healthcare needs, positioning itself for sustained growth in the expanding global diagnostics market. With a strong emphasis on accessibility and innovation, the company is well-placed to capitalize on increasing demand for decentralized and point-of-care testing.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation Point-of-Care Diagnostic Platform70% success
• Q4 2026Expansion into Latin American Markets via New Distribution Agreements60% success
• Q1 2027Strategic Partnership with a Major Global Health Organization for Infectious Disease Testing50% success